Opinion
Video
Author(s):
Expert oncologists give an overview of prostate-specific membrane antigen (PSMA) and discuss its utility for the treatment of prostate cancer.
Pivotal trial launches of 64Cu-SAR-bisPSMA in BCR of prostate cancer
Pearls & Perspectives: Helen Bernie, DO, MPH, at AUA 2025
Study shows value of precision-based approaches in prostate cancer
Dr. Murphy on increasing diversity in cancer clinical trials
Telehealth in urologic cancer: Lessons learned from the COVID-19 pandemic
MRI and focal therapy may enable men on AS to safely delay surgery or radiation